论文部分内容阅读
Objective Telomerase reverse transcriptase (TERT) promoter mutations have recently been describedin thyroid carcinoma. The purpose of this study was to investigate the clinical significance of (v-raf murinesarcoma viral oncogene homolog B1) BRAF V600E and